Financial Performance - The company's operating revenue for Q3 2022 reached ¥806,325,053.31, representing a year-on-year increase of 70.55%[4] - The net profit attributable to shareholders for Q3 2022 was ¥126,936,250.46, a significant increase of 417.94% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥166,851,209.04, reflecting a year-on-year increase of 682.61%[4] - The basic earnings per share for Q3 2022 was ¥0.41, up 412.50% from the previous year[4] - In Q3 2022, the company's net profit reached CNY 324,750,870.95, a significant increase from CNY 83,769,439.41 in Q3 2021, representing a growth of approximately 287%[18] - The operating profit for Q3 2022 was CNY 354,997,648.41, compared to CNY 103,342,701.13 in the same period last year, indicating a year-over-year increase of about 243%[18] - Basic and diluted earnings per share for Q3 2022 were CNY 1.05, compared to CNY 0.27 in Q3 2021, representing an increase of approximately 288%[19] - The total comprehensive income for Q3 2022 was CNY 324,750,870.95, compared to CNY 83,769,439.41 in Q3 2021, indicating a substantial increase of approximately 287%[19] Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached CNY 2,470,082,481.24, a significant increase from CNY 1,510,387,837.24 in the same period of 2021, representing a growth of approximately 63.6%[17] - Total operating costs for the first three quarters of 2022 were CNY 2,042,916,592.88, compared to CNY 1,415,898,719.61 in the previous year, indicating an increase of about 44.2%[17] - Total revenue from sales of goods and services for the first nine months of 2022 was CNY 2,184,624,331.87, compared to CNY 1,346,003,199.90 in the previous year, marking an increase of about 62%[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,585,644,377.72, an increase of 31.58% compared to the end of the previous year[4] - As of September 30, 2022, total current assets were CNY 2,372,738,937.65, compared to CNY 1,668,730,530.62 at the end of 2021, marking an increase of about 42.3%[13] - Total liabilities as of September 30, 2022, were CNY 1,467,765,933.31, up from CNY 887,227,964.67 at the end of 2021, representing an increase of approximately 65.4%[14] - The total assets of the company reached CNY 3,585,644,377.72 as of September 30, 2022, compared to CNY 2,725,106,027.36 at the end of 2021, indicating a growth of approximately 31.6%[15] - The company's equity attributable to shareholders was CNY 2,117,878,444.41 as of September 30, 2022, compared to CNY 1,837,878,062.69 at the end of 2021, reflecting an increase of about 15.3%[15] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥463,735,849.03, showing a year-on-year increase of 470.40%[4] - Cash flow from operating activities for the first nine months of 2022 was CNY 463,735,849.03, up from CNY 81,299,975.73 in the same period of 2021, reflecting a growth of approximately 471%[22] - The company reported a net cash outflow from investing activities of CNY -582,409,775.93 in the first nine months of 2022, compared to CNY -311,521,138.17 in the same period of 2021[23] - The cash and cash equivalents at the end of Q3 2022 stood at CNY 229,654,525.04, a decrease from CNY 54,123,376.46 at the end of Q3 2021[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,561[10] - The largest shareholder, Wang Xianquan, held 33.16% of the shares, totaling 103,002,099 shares[10] Research and Development - Research and development expenses for the first three quarters of 2022 amounted to CNY 108,269,538.33, up from CNY 74,798,721.60 in 2021, reflecting a growth of approximately 44.7%[17] - Research and development expenses for Q3 2022 were ¥40,166,908.95, compared to ¥34,805,579.34 in Q3 2021, reflecting increased investment in innovation[29] Inventory and Accounts Receivable - The company experienced a significant increase in accounts receivable, which rose to CNY 385,251,684.70 as of September 30, 2022, from CNY 267,623,227.59 at the end of 2021, reflecting a growth of about 44%[25] - The company's inventory decreased from ¥208,276,941.28 to ¥191,642,386.56, indicating improved inventory management[26]

Financial Performance - The company's operating revenue for the first half of 2022 reached ¥1,663,757,427.93, representing a 60.35% increase compared to ¥1,037,610,224.84 in the same period last year[18]. - Net profit attributable to shareholders was ¥197,814,620.49, a significant increase of 233.80% from ¥59,261,649.65 in the previous year[18]. - The net cash flow from operating activities was ¥246,870,494.55, a remarkable turnaround from a negative cash flow of ¥55,362,649.08 in the same period last year, marking a 545.92% improvement[18]. - Basic earnings per share increased to ¥0.64, up 236.84% from ¥0.19 in the same period last year[19]. - The weighted average return on net assets improved to 10.21%, an increase of 6.74 percentage points from 3.47% in the previous year[19]. - The company reported a significant increase in trading financial assets, which reached CNY 324,460,189.59, up 3,601.65% from CNY 8,765,289.60[48]. - The company reported a notable increase in development expenditures to ¥26,607,894.47, up from ¥13,962,518.98, which is an increase of approximately 90.9%[108]. - The company recorded a significant increase in operating profit, which reached ¥216,751,993.82, compared to ¥73,224,800.13 in the first half of 2021[116]. Assets and Liabilities - The total assets of the company increased by 24.67% to ¥3,397,391,683.24 from ¥2,725,106,027.36 at the end of the previous year[18]. - Total liabilities rose to ¥1,410,198,479.27, compared to ¥887,227,964.67, indicating an increase of about 58.9%[109]. - Owner's equity reached ¥1,987,193,203.97, up from ¥1,837,878,062.69, reflecting a growth of approximately 8.1%[109]. - The total current assets increased to CNY 2,270,561,727.34 from CNY 1,668,730,530.62, reflecting a growth of approximately 36%[107]. - The total non-current assets amounted to ¥1,126,829,955.90, compared to ¥1,056,375,496.74, showing a growth of about 6.6%[108]. Research and Development - The company maintains a focus on research and development, collaborating with universities to enhance its innovation capabilities and product development[30]. - Research and development expenses rose to CNY 66,752,561.05, marking a 36.70% increase from CNY 48,831,986.77, reflecting the company's commitment to innovation[44][45]. - The company has established a strong R&D team and increased investment in R&D, leading to the successful market launch of new products such as quikazone[33]. - The company is investing heavily in R&D, with a budget allocation of 200 million RMB for new technology development[85]. Market Position and Strategy - The company is positioned as a leader in the selective herbicide segment, leveraging advantages in technology innovation, quality, scale, and brand[32]. - The company achieved overseas sales of $145 million in the first half of 2022, surpassing the total export amount for the entire year of 2021[40]. - The company has established a comprehensive sales model, including direct sales to domestic agricultural enterprises and both self-operated and indirect exports for international markets[31]. - The company plans to continue focusing on market expansion and new product development to sustain growth in the upcoming quarters[118]. Environmental Responsibility - The company’s pollution prevention facilities operated normally, with wastewater and air emissions meeting standards[61]. - The company has not reported any environmental pollution incidents during the reporting period[61]. - The company has established various environmental protection facilities, including RTO regenerative thermal oxidizers and multiple wastewater treatment technologies, which are operating normally during the reporting period[71]. - The company is committed to reducing carbon emissions and has taken measures to fulfill its environmental responsibilities, although specific details were not disclosed in the report[78]. Shareholder Information - The company distributed cash dividends of 5,547.15 million (including tax) to shareholders, with a payout of 2.50 RMB per 10 shares[93]. - The number of ordinary shareholders reached 15,013 by the end of the reporting period[97]. - The largest shareholder, Wang Xianquan, holds 103,002,099 shares, representing 33.16% of the total shares[99]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties[90]. Financial Reporting and Governance - The company approved the 2021 annual financial report and budget for 2022 during the shareholder meeting[55]. - The company's financial statements were approved by the board of directors on August 18, 2022[144]. - The financial statements are prepared based on the assumption of going concern, in accordance with the relevant accounting standards[149]. - The company has evaluated its ability to continue as a going concern for the next 12 months and found no significant doubts regarding its ability to continue operations[147].

Financial Performance - The company's operating revenue for 2021 was CNY 2,202,538,106.69, representing a 16.19% increase compared to CNY 1,895,595,666.25 in 2020[19]. - The net profit attributable to shareholders of the listed company was CNY 177,380,335.82, a slight increase of 0.76% from CNY 176,034,335.10 in the previous year[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 8.66% to CNY 150,648,746.13 from CNY 164,940,201.50 in 2020[19]. - The net cash flow from operating activities was CNY 224,108,606.00, down 37.99% from CNY 361,385,546.72 in 2020[19]. - The total assets at the end of 2021 were CNY 2,725,106,027.36, an increase of 16.71% from CNY 2,335,002,206.40 at the end of 2020[19]. - The net assets attributable to shareholders of the listed company increased by 7.87% to CNY 1,837,878,062.69 from CNY 1,703,781,974.56 in 2020[19]. - The company's asset-liability ratio stood at 32.56%[25]. - Operating costs increased to CNY 1,701,380,763.24, reflecting a year-on-year rise of 24.34% due to higher sales volume and raw material prices[37]. - The gross profit margin for the main business decreased by 5.08 percentage points to 22.70%[40]. - Domestic sales revenue was CNY 807,129,049.04, with a decrease in gross margin by 12.51 percentage points to 16.77%[40]. Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 2.50 per 10 shares, totaling CNY 55,471,500, with a cash dividend payout ratio of 31.27%[3]. - The company distributed cash dividends of 3.50 RMB per 10 shares, totaling 55.47 million RMB[20]. - The company implements a stable profit distribution policy, prioritizing cash dividends, with a minimum annual cash distribution of 10% of the net profit attributable to shareholders[135]. - The cumulative distributable profit of the company is positive, and the company has no major investment plans or significant cash expenditures exceeding 30% of the latest audited net assets within the next twelve months[135]. - The company aims to distribute at least 30% of the average distributable profit over three consecutive years in cash dividends, provided there are no unremedied losses from previous years[136]. - The company has a cash dividend policy that allows for mid-term distributions based on the company's profitability and funding needs[135]. Research and Development - Research and development expenses amounted to CNY 98,060,123.52, up by 2.18% from the previous year[37]. - The company employed 187 R&D personnel, representing 10.75% of the total workforce[48]. - The company has established partnerships with universities for collaborative research on new compound development, enhancing its technological innovation capabilities[67]. - The company is focusing on high-end formulation registration and overseas market development, achieving significant benefits in 2021[28]. - The company is advancing the registration of innovative compounds domestically and expanding its overseas market registration efforts, targeting Southeast Asia, Central America, and Latin America[102]. Production and Capacity - The company expanded production capacity with the successful trial production of two major raw material workshops, increasing annual production capacity by 5,000 tons[25]. - The company's production capacity for acetochlor is 3,000 tons annually, with an additional 5,000 tons in trial production, further consolidating its market position[34]. - The company's herbicide production capacity is designed at 13,500 tons with a utilization rate of 69.31%[73]. - The fungicide production capacity is designed at 2,500 tons with a utilization rate of 100.32% and an additional 5,000 tons under construction expected to be completed by June 2022[73]. Environmental Compliance - The company maintained compliance with environmental regulations, with wastewater and air emissions meeting the required standards[149][150]. - The total annual COD discharge was 3.827 tons, with a concentration of 97.10 mg/L, well within the permitted limits[149]. - The company has implemented various environmental protection facilities, including RTO thermal oxidation systems and wastewater treatment technologies, which are operating normally[157]. - The company emphasizes strict safety management and has enhanced training and emergency response capabilities to improve risk control in production safety[165]. Corporate Governance - The company maintained strict compliance with the Company Law and relevant regulations, ensuring no guarantees were provided to controlling shareholders or their affiliates[107]. - The company has implemented measures to maintain independence from its controlling shareholders in terms of assets, personnel, finance, and operations[107]. - The company’s independent directors have not reported any conflicts of interest or significant changes in competitive conditions affecting the company[108]. - The company has successfully completed the election of its fourth board of directors and supervisory board during the annual general meeting[108]. Market Position and Strategy - The company is a leading player in the selective herbicide segment, focusing on technological innovation in herbicide varieties and application techniques, with major products ranking among the top in domestic production capacity[61]. - The company is actively pursuing the development of environmentally friendly pesticides in response to increasing demand for green products and stricter regulations[30]. - The company aims to enhance its domestic market product innovation and reduce reliance on foreign markets, aiming to develop high-value products and increase domestic marketing efforts[89]. Risk Management - The company faces market competition risks due to increased product input from international pesticide giants and domestic competitors, which may lead to price declines and reduced profit margins[103]. - The company is exposed to raw material price volatility risks, primarily influenced by international oil prices and market supply-demand dynamics, which could impact operational performance[103]. - The company has implemented a performance evaluation system reform to enhance management quality and incentivize productivity through clear metrics and accountability[99].

Revenue and Profitability - Revenue for Q1 2022 reached ¥561,203,087.34, an increase of 25.80% compared to the same period last year[5] - Net profit attributable to shareholders was ¥75,757,675.73, representing a significant increase of 266.00% year-on-year[5] - Basic earnings per share (EPS) stood at ¥0.34, up 161.54% from the same quarter last year[5] - Total operating revenue for Q1 2022 was CNY 561,203,087.34, an increase of 25.8% compared to CNY 446,091,252.68 in Q1 2021[14] - Net profit for Q1 2022 reached CNY 75,757,675.73, compared to CNY 20,699,023.43 in Q1 2021, representing a significant increase of 265.5%[15] - Earnings per share for Q1 2022 were CNY 0.34, up from CNY 0.13 in Q1 2021, indicating a growth of 161.5%[15] - The company reported a total profit of CNY 86,965,183.79 for Q1 2022, compared to CNY 24,426,239.64 in Q1 2021, representing an increase of 256.1%[15] - The total operating profit for Q1 2022 was CNY 33,230,173.58, up from CNY 7,190,812.33 in the same period last year, indicating a growth of 361.5%[25] Cash Flow and Liquidity - Net cash flow from operating activities was ¥113,749,921.62, a remarkable increase of 481.43% compared to the previous year[5] - The net cash flow from operating activities for Q1 2022 was ¥113,749,921.62, a significant improvement compared to a negative cash flow of ¥29,821,973.74 in Q1 2021, indicating a recovery in operational performance[18] - Cash received from sales of goods and services in Q1 2022 was CNY 591,658,321.58, compared to CNY 422,634,877.90 in Q1 2021, marking an increase of 40.0%[17] - The cash flow from operating activities showed a net outflow of CNY 17,235,351.07 in Q1 2022, worsening from a net outflow of CNY 9,212,901.32 in Q1 2021[28] - Cash and cash equivalents at the end of Q1 2022 amounted to CNY 91,860,903.25, an increase from CNY 53,860,548.77 at the end of Q1 2021[28] Assets and Liabilities - Total assets increased by 13.82% to ¥3,101,582,176.71 compared to the end of the previous year[5] - Total current assets as of March 31, 2022, amounted to CNY 2,026,075,092.48, an increase from CNY 1,668,730,530.62 at the end of 2021[11] - Total liabilities as of Q1 2022 amounted to CNY 1,184,633,191.61, compared to CNY 887,227,964.67 in the previous year, reflecting a growth of 33.5%[14] - The total liabilities amounted to ¥618,148,538.00, up from ¥416,530,570.00 in the previous year, reflecting increased financial obligations[23] - The company reported a total asset value of ¥2,046,473,077.68 as of March 31, 2022, an increase from ¥1,814,865,669.72 at the end of 2021[22] Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,110[8] - The top 10 shareholders hold a combined 80.92% of the shares, with the largest shareholder, Wang Xianquan, owning 33.16%[8] - Total equity attributable to shareholders reached CNY 1,916,948,985.10 in Q1 2022, up from CNY 1,837,878,062.69 in Q1 2021, an increase of 4.3%[14] - The company’s equity totaled ¥1,428,324,539.68 as of March 31, 2022, compared to ¥1,398,335,099.72 at the end of 2021, showing a slight increase in shareholder equity[23] Research and Development - Research and development expenditures increased by 30.09% to ¥18,163,243.01, reflecting higher investment in compound development[7] - Research and development expenses for Q1 2022 were CNY 25,535,345.90, compared to CNY 22,991,964.88 in Q1 2021, showing an increase of 11.0%[14] - Research and development expenses for Q1 2022 were CNY 10,219,808.23, slightly down from CNY 11,110,406.19 in Q1 2021[24] Inventory and Borrowings - The company reported a 34.13% increase in inventory, totaling ¥684,072,180.17, due to preparations for domestic market product sales[7] - Short-term borrowings rose by 200.00% to ¥90,000,000.00, aimed at increasing cash flow reserves for operations[7] - Short-term borrowings rose to CNY 90,000,000.00 from CNY 30,000,000.00, indicating a significant increase in leverage[11] - Inventory increased to CNY 684,072,180.17 from CNY 510,019,926.59 at the end of 2021, reflecting a growth of approximately 34.1%[10] Other Financial Metrics - The weighted average return on equity (ROE) improved by 2.83 percentage points to 4.04%[5] - Non-recurring gains and losses totaled ¥6,040,845.40 after tax adjustments[6] - The deferred income tax liabilities decreased to CNY 531,239.89 in Q1 2022 from CNY 1,220,237.19 in Q1 2021, a reduction of 56.4%[14] - The company reported a financial income of CNY 806,444.10 in Q1 2022, a recovery from a loss of CNY 1,731,699.66 in Q1 2021[25] - The total comprehensive income for Q1 2022 was CNY 28,438,459.17, which is the same as the net profit, indicating no other comprehensive income items[25]

Group 1: Event Details - The company will participate in the "2021 Annual Investor Online Reception Day" on November 16, 2021 [2] - The event will be held online from 14:00 to 16:00 [2] - Investors can join the event via the "Panjing Roadshow" website [2] Group 2: Company Representatives - The company's Secretary of the Board, Jiang Guangtong, will participate in the event [2] - The Chief Financial Officer, Jiang Guangtong, will also be present [2] - The Securities Affairs Representative, Han Enjuan, will engage with investors during the event [2] Group 3: Purpose and Commitment - The event aims to enhance interaction and communication with investors [2] - The company emphasizes the accuracy and completeness of the announcement, ensuring no misleading information is presented [2]

公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 2021 年第三季度报告 证券代码：603086 证券简称：先达股份 山东先达农化股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 | | 年初至报告期末 比上年同期增减 | | --- | --- | --- | --- | --- | | | | 年同期增减变 | 年初至报告期末 | | | | | 动幅度(%) | | 变动幅度(%) | | 营业收入 | 472,777,612.40 | 29.28 | 1,510,387,837.24 | 13.4 ...

Financial Performance - The company's operating revenue for the first half of 2021 was approximately CNY 1,037.61 million, representing a year-on-year increase of 7.47% compared to CNY 965.51 million in the same period last year[17]. - The net profit attributable to shareholders of the listed company decreased by 38.18% to CNY 59.26 million, down from CNY 95.86 million in the previous year[17]. - Basic earnings per share decreased by 37.21% to CNY 0.27, down from CNY 0.43 in the same period last year[18]. - The gross profit margin decreased to 20.14%, down 11.39 percentage points from the previous year[33]. - The company reported a comprehensive income of CNY 59,261,649.65 for the first half of 2021[121]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -55.36 million, a significant decline of 219.76% compared to CNY 46.23 million in the same period last year[17]. - Cash flow from operating activities showed a net outflow of CNY 55,362,649.08, compared to a net inflow of CNY 46,228,827.78 in the first half of 2020[113]. - The company's cash and cash equivalents decreased to CNY 312,622,576.84 from CNY 505,708,846.56, a decline of approximately 38.19%[98]. - The company's cash and cash equivalents at the end of the period were CNY 56,763,896.78, down from CNY 82,787,763.32 at the end of the previous year[118]. Assets and Liabilities - The total assets of the company increased by 3.48% to CNY 2,416.16 million, compared to CNY 2,335.00 million at the end of the previous year[17]. - Total liabilities increased to CNY 702,711,889.19 from CNY 631,220,231.84, which is an increase of approximately 11.32%[100]. - The company's equity attributable to shareholders was CNY 1,713,448,380.31, slightly up from CNY 1,703,781,974.56, showing a marginal increase of about 0.43%[100]. Research and Development - The company has established a complete R&D, procurement, production, quality inspection, marketing, and sales system to ensure stable and healthy development[23]. - The company has developed a patented compound, Quikazone, which is the first new pesticide approved for use in sorghum fields, addressing a significant market gap[29]. - Research and development expenses for the first half of 2021 were ¥48,831,986.77, compared to ¥50,862,648.69 in the same period of 2020[106]. Environmental Compliance - The company’s wastewater discharge total was 4.76 tons with a concentration of 168 mg/L, which is within the permitted limits[56]. - The company has maintained effective pollution control measures, ensuring no environmental pollution incidents occurred during the reporting period[55]. - The company reported no significant administrative penalties related to environmental issues during the reporting period[70]. Shareholder Information - The company distributed cash dividends of CNY 55.47 million (including tax) to shareholders, with a payout of CNY 3.50 per 10 shares[85]. - The largest shareholder, Wang Xianquan, increased his holdings by 21,020,837 shares, bringing his total to 73,572,928 shares, representing 33.16% of the total shares[90]. - The total number of ordinary shareholders reached 10,366 by the end of the reporting period[88]. Market Position and Industry Outlook - The company is a leader in the selective herbicide segment, emphasizing technological research and development, quality, scale, and brand strength[29]. - The company anticipates challenges in the pesticide industry due to intensified competition and increased regulatory scrutiny[27]. - The agricultural sector is expected to benefit from increased investment in high-quality production materials due to rising farmer incomes and supportive government policies[28]. Corporate Governance - The company has made changes in its board and management personnel, including the election of a new general manager and independent directors[51]. - The company has not reported any significant environmental information updates or changes during the reporting period[70]. - The financial statements were approved by the board of directors on August 27, 2021, ensuring compliance with regulatory requirements[134].

Financial Performance - The company's operating revenue for 2020 was CNY 1,895,595,666.25, representing a year-on-year increase of 20.39% compared to CNY 1,574,570,054.14 in 2019[17]. - The net profit attributable to shareholders of the listed company was CNY 176,034,335.10, a decrease of 13.97% from CNY 204,618,341.01 in the previous year[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 164,940,201.50, down 22.42% from CNY 212,593,825.35 in 2019[17]. - The net cash flow from operating activities was CNY 361,385,546.72, a decline of 9.55% compared to CNY 399,562,923.76 in 2019[17]. - Basic earnings per share decreased by 13.85% to CNY 1.12 in 2020 compared to CNY 1.30 in 2019[19]. - The weighted average return on equity increased by 1.89 percentage points to 10.81% in 2020 from 8.92% in 2019[19]. - The company reported a decline in operating profit to 228.25 million yuan, a decrease of 5.66% year-on-year, due to external market pressures[35]. - Revenue for the year reached CNY 1,895.60 million, representing a year-on-year growth of 20.39%, while operating costs increased by 34.18% to CNY 1,368.29 million[44][46]. Assets and Liabilities - The total assets at the end of 2020 were CNY 2,335,002,206.40, an increase of 1.34% from CNY 2,304,145,473.28 at the end of 2019[18]. - The net assets attributable to shareholders of the listed company were CNY 1,703,781,974.56, reflecting a growth of 9.41% from CNY 1,557,176,380.70 in 2019[18]. - Trading financial assets increased to ¥80,384,715.04, accounting for 3.44% of total assets, up 44.00% from the previous period[58]. - Accounts receivable decreased to ¥207,747,577.03, representing 8.90% of total assets, down 27.52% from the previous period[58]. - Fixed assets rose to ¥537,175,841.18, making up 23.01% of total assets, an increase of 59.25% compared to the previous period[59]. - Contract liabilities grew to ¥108,252,970.88, representing 4.64% of total liabilities, an increase of 30.85% from the previous period[59]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 3.50 per 10 shares, totaling CNY 55,471,500, with a cash dividend payout ratio of 31.51%[3]. - The company distributed cash dividends of CNY 3.00 per 10 shares, totaling CNY 33.60 million, and increased share capital by 4.48 million shares[19]. - In 2020, the company distributed a cash dividend of 3.50 RMB per 10 shares, totaling 55,471,500 RMB, which represents 31.51% of the net profit attributable to ordinary shareholders[138]. - In 2019, the cash dividend was 3.00 RMB per 10 shares, amounting to 33,600,000 RMB, accounting for 16.42% of the net profit attributable to ordinary shareholders[138]. Research and Development - The company established a research collaboration with Guizhou University in 2020 to enhance its technological innovation capabilities[26]. - The company is recognized as a national high-tech enterprise with a strong R&D team primarily composed of PhD and master's degree holders, focusing on the development of new herbicides and fungicides[31]. - The company has established a technology innovation research institute in collaboration with universities to enhance its R&D capabilities and product offerings[31]. - The company is actively pursuing new product development and has signed a research collaboration agreement with Guizhou University to create new compounds[88]. - Research and development expenses increased by 16.45% to CNY 95.96 million, accounting for 5.06% of total revenue[53][56]. Market and Product Development - The company is actively pursuing market expansion and integration within the agricultural chemical industry, driven by national policies and regulations[29]. - The company launched a new patented compound, Quikazone, which is the first herbicide approved for use in sorghum fields, filling a gap in the market[38]. - The company launched new products, including a 30% benzylacetone suspension agent and a 43% benzylacetone and mesotrione suspension agent, addressing resistant weeds in corn production[40]. - The company is expanding its product line with new offerings such as the "Zhanma Bai" series for resistant weed control and new fungicide formulations, while also increasing marketing efforts to enhance market penetration[125]. Environmental Management - The company has implemented a comprehensive environmental management system, ensuring that wastewater and emissions meet regulatory standards[165]. - The total COD emissions for the year were 14.415 tons, with a concentration of 323 mg/L, which is within the permitted limits[166]. - The company has implemented various environmental protection facilities, including RTO regenerative thermal oxidizers and wastewater treatment systems[176]. - Emergency response plans for environmental incidents have been established and drills conducted in accordance with regulatory requirements[179]. Corporate Governance and Compliance - The company has appointed Dahua Certified Public Accountants (Special General Partnership) as the auditing firm for the 2020 fiscal year, with an audit fee of RMB 500,000[146]. - The company has not faced any major litigation or arbitration matters during the reporting period[148]. - The company has not received any penalties from the China Securities Regulatory Commission or other relevant departments during the reporting period[148]. - The company has not reported any significant changes in accounting policies or estimates during the reporting period[145]. - The company has not faced any risks of suspension or termination of its listing[148]. Risk Management - The company is enhancing its risk management framework to address market competition, raw material price fluctuations, exchange rate changes, and safety and environmental risks[126][128][129][130]. - The company has established long-term procurement contracts with major suppliers to mitigate risks associated with raw material price fluctuations[99]. - The company has a commitment to repurchase shares if the prospectus is found to have false statements or omissions, with the repurchase price set at the issuance price[142]. Shareholder Structure - The largest shareholder, Wang Xianquan, holds 52,552,091 shares, representing 33.16% of the total shares[190]. - The company’s total number of shares held by domestic natural persons is 39,486,257, accounting for 35.2% of the total shares[182]. - The total number of ordinary shares increased from 112 million to 158.49 million after a capital reserve conversion of 44.8 million shares[184]. - The company’s total share capital after the incentive plan is 15,849 million shares[184].

Financial Performance - Operating revenue for the period reached CNY 446,091,252.68, representing a 21.17% increase year-on-year[7] - Net profit attributable to shareholders decreased by 17.03% to CNY 20,699,023.43 compared to the same period last year[7] - Basic earnings per share fell by 18.75% to CNY 0.13[7] - Net profit for Q1 2021 decreased to CNY 20,699,023.43, down 17.03% from CNY 24,946,636.61 in the same period last year[24] - Total operating revenue for Q1 2021 reached ¥446,091,252.68, an increase of 21.2% compared to ¥368,138,134.73 in Q1 2020[38] - Net profit for Q1 2021 was ¥20,699,023.43, a decrease of 17.5% from ¥24,946,636.61 in Q1 2020[39] - The total comprehensive income for Q1 2021 was CNY 6,575,018.23, compared to CNY 4,962,516.98 in Q1 2020[43] Cash Flow - The net cash flow from operating activities was negative at CNY -29,821,973.74, a decline of 430.14% year-on-year[7] - The company's cash flow from operating activities showed a significant decline, with a net outflow of CNY 29,821,973.74 compared to a net outflow of CNY 5,625,279.46 in Q1 2020, representing a decrease of 430.14%[25] - The company reported a net cash outflow from operating activities of CNY -29,821,973.74, compared to CNY -5,625,279.46 in Q1 2020[44] - The total operating cash inflow for Q1 2021 was CNY 455,133,081.22, compared to CNY 343,002,617.22 in Q1 2020, marking a 32.7% increase[44] - The company incurred a total cash outflow from operating activities of 272,316,662.93 RMB, compared to 222,181,917.31 RMB in the previous year, representing an increase of about 22.6%[48] - The company's cash outflow for purchasing goods and services was 241,658,325.24 RMB, which increased from 181,689,367.08 RMB in the same quarter last year, indicating a rise of approximately 33%[48] Assets and Liabilities - Total assets increased by 7.59% to CNY 2,512,181,645.71 compared to the end of the previous year[7] - Cash and cash equivalents decreased by 33.05% to CNY 338,587,958.50 compared to the beginning of the year[12] - Trade receivables increased by 49.93% to CNY 311,467,749.93 compared to the beginning of the year[12] - Total liabilities increased to ¥351,955,421.11 in Q1 2021 from ¥249,900,595.95 in Q1 2020, representing a significant rise of 40.9%[37] - The company's total assets as of March 31, 2021, amounted to ¥1,747,910,175.73, compared to ¥1,637,676,415.33 at the end of 2020, indicating a growth of 6.7%[37] Expenses - Total operating costs for Q1 2021 were ¥422,744,540.39, up from ¥331,026,874.30 in Q1 2020, reflecting a year-over-year increase of 27.6%[38] - Research and development expenses for Q1 2021 were ¥22,991,964.88, an increase of 19.0% compared to ¥19,234,223.50 in Q1 2020[39] - Research and development expenses rose to CNY 11,110,406.19, up 21.2% from CNY 9,162,932.26 in Q1 2020[42] - Sales expenses decreased significantly to CNY 1,822,084.78 from CNY 3,727,478.57 in Q1 2020, a reduction of 51%[42] Government Support and Tax - The company received government subsidies amounting to CNY 295,997.91, which are closely related to its normal business operations[7] - The company reported a significant increase in tax payable, which rose by 271.77% to CNY 5,482,529.76 from CNY 1,474,708.92 in Q1 2020[11] - The company received CNY 30,537,480.10 in tax refunds, an increase from CNY 16,637,196.88 in Q1 2020[44] Investment and Income - Investment income for Q1 2021 was CNY 2,685,318.92, a turnaround from a loss of CNY 1,219,736.93 in the same period last year, marking a 320.16% improvement[22] - The fair value change income decreased significantly, reporting a loss of CNY 2,246,255.66 compared to a loss of CNY 567,339.80 in Q1 2020, reflecting a decline of 295.93%[23] - The company generated 241,964,271.79 RMB from sales of goods and services, a significant increase from 155,222,552.20 RMB in Q1 2020, reflecting a growth of approximately 55.7%[48] Shareholder Information - The total number of shareholders reached 9,217 by the end of the reporting period[10]

Financial Performance - Net profit attributable to shareholders decreased by 18.69% to CNY 122,378,057.99 for the first nine months of the year[6] - Operating revenue for the first nine months increased by 15.55% to CNY 1,331,213,129.95 compared to the same period last year[6] - Basic earnings per share decreased by 18.75% to CNY 0.78[6] - The company reported a decrease in net profit excluding non-recurring gains and losses by 17.31% to CNY 128,214,446.92[6] - Net profit for the first three quarters of 2020 reached CNY 166,213,870.54, compared to CNY 190,144,270.57 in the same period of 2019, indicating a decrease of 12.6%[32] - Net profit for Q3 2020 was CNY 13,499,836.96, a decrease from CNY 33,479,587.25 in Q3 2019, representing a decline of approximately 60.3%[37] - Total comprehensive income for Q3 2020 was CNY 13,499,836.96, down from CNY 33,479,587.25 in Q3 2019, indicating a decline of about 60.3%[38] Assets and Liabilities - Total assets increased by 5.86% to CNY 2,439,274,051.01 compared to the end of the previous year[6] - The company's total assets as of September 30, 2020, amounted to CNY 1,733,406,586.31, an increase from CNY 1,577,122,340.16 at the end of 2019[29] - Total liabilities increased to CNY 360,798,950.39 as of September 30, 2020, compared to CNY 227,034,702.88 at the end of 2019, representing a 58.7% rise[29] - The total liabilities as of Q3 2020 amounted to 746,969,092.58 RMB, unchanged from the previous year, indicating stable financial obligations[47] - The total assets as of Q3 2020 were 2,304,145,473.28 RMB, consistent with the previous year, reflecting a stable asset base[47] Cash Flow - Net cash flow from operating activities increased by 3.85% to CNY 268,752,340.95 for the first nine months[6] - Cash flow from operating activities for the first nine months of 2020 was CNY 1,437,975,150.98, an increase from CNY 1,234,205,852.06 in the same period of 2019, reflecting a growth of approximately 16.6%[39] - Cash flow from investing activities showed a net outflow of CNY 298,360,992.03 in the first nine months of 2020, an improvement from a net outflow of CNY 549,132,258.32 in the same period of 2019[40] - The net cash flow from investment activities was -112,099,495.68 RMB in 2020, an improvement compared to -191,105,479.31 RMB in 2019, showing a reduction in losses by approximately 41.4%[42] - The company reported a net cash decrease of CNY 182,709,746.93 in Q3 2020, compared to a decrease of CNY 137,821,511.84 in Q3 2019[41] Shareholder Information - The total number of shareholders reached 7,655 by the end of the reporting period[9] - The top ten shareholders held a total of 33.16% of the shares, with the largest shareholder owning 52,552,091 shares[10] Research and Development - Research and development expenses increased by 31.09% to ¥77,869,394.91 from ¥59,401,364.38[16] - Research and development expenses for the first three quarters of 2020 were CNY 77,869,394.91, up from CNY 59,401,364.38 in the same period of 2019, reflecting a 30.9% increase[32] - R&D expenses in Q3 2020 amounted to ¥15,473,759.51, a 56.0% increase from ¥9,886,436.61 in Q3 2019[36] Investment and Financial Assets - Trading financial assets increased significantly by 377.07% to ¥266,312,210.00 from ¥55,822,821.60[12] - Investment income turned positive at ¥6,967,634.16 compared to a loss of ¥6,988,958.34 in the previous period[19] Operating Costs - Total operating costs for Q3 2020 were CNY 339,834,610.20, up from CNY 262,322,664.53 in Q3 2019, reflecting a 29.6% increase[32] - Operating expenses for Q3 2020 totaled CNY 1,169,222,810.03, up from CNY 975,405,375.60 in Q3 2019, reflecting an increase of about 19.8%[40] Inventory and Prepayments - The company’s inventory as of September 30, 2020, was CNY 194,760,382.08, an increase from CNY 162,745,047.66 in the previous year[28] - Prepayments rose by 104.98% to ¥30,061,970.19 from ¥14,665,853.92[13] - The company reported a decrease in prepayments by RMB 35,812,891.19, indicating a potential shift in cash flow management[50]